Dr. Reddy’s Laboratories Revenue: Proven Growth in Q2 FY27
Dr. Reddy’s Laboratories revenue shows a significant rise in Q2 FY27, reaching ₹8,671 crore, indicating strong performance.
Dr. Reddy’s Laboratories revenue shows a significant rise in Q2 FY27, reaching ₹8,671 crore, indicating strong performance.
Silver rate today has hit an 11-month low, slipping below ₹2 lakh in India. What does this mean for buyers?
The washable smart sleeve is a revolutionary wearable tech innovation.
SK Hynix IPO news reveals Solidigm’s decision to drop US IPO plans amid market volatility.